{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:00:03Z","timestamp":1767650403463},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"partly funded by UCB Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00223-016-0109-7","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T08:19:04Z","timestamp":1454487544000},"page":"556-565","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health"],"prefix":"10.1007","volume":"98","author":[{"given":"Tahir","family":"Hakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra J.","family":"Petty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Sakellarides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemma","family":"Christie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Todaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Yerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Wark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"109_CR1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S8756-3282(02)00848-7","volume":"31","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31:508\u2013514","journal-title":"Bone"},{"key":"109_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk\u2014a meta-analysis. Acta Neurol Scand 112:277\u2013286","journal-title":"Acta Neurol Scand"},{"key":"109_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000324919.86696.a9","volume":"71","author":"KE Ensrud","year":"2008","unstructured":"Ensrud KE, Walczak TS, Blackwell TL, Ensrud ER, Barrett-Connor E, Orwoll ES (2008) Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 71:723\u2013730","journal-title":"Neurology"},{"key":"109_CR4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000180910.72487.18","volume":"65","author":"SJ Petty","year":"2005","unstructured":"Petty SJ, Paton LM, O\u2019Brien TJ, Makovey J, Erbas B, Sambrook P, Berkovic SF, Wark JD (2005) Effect of antiepileptic medication on bone mineral measures. Neurology 65:1358\u20131365","journal-title":"Neurology"},{"key":"109_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.20378","volume":"57","author":"AM Pack","year":"2005","unstructured":"Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E (2005) Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57:252\u2013257","journal-title":"Ann Neurol"},{"key":"109_CR6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","volume":"70","author":"AM Pack","year":"2008","unstructured":"Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E (2008) Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70:1586\u20131593","journal-title":"Neurology"},{"key":"109_CR7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","volume":"59","author":"DL Andress","year":"2002","unstructured":"Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59:781\u2013786","journal-title":"Arch Neurol"},{"key":"109_CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","volume":"46","author":"P Souverein","year":"2005","unstructured":"Souverein P, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T (2005) Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the general practice research database. Epilepsia 46:304\u2013310","journal-title":"Epilepsia"},{"key":"109_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11940-011-0133-x","volume":"13","author":"AM Pack","year":"2011","unstructured":"Pack AM (2011) Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol 13:346\u2013354","journal-title":"Curr Treat Options Neurol"},{"key":"109_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","volume":"57","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57:445\u2013449","journal-title":"Neurology"},{"key":"109_CR11","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"JA French","year":"2004","unstructured":"French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA (2004) Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62:1252\u20131260","journal-title":"Neurology"},{"key":"109_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yebeh.2011.05.001","volume":"21","author":"AM Pack","year":"2011","unstructured":"Pack AM, Morrell MJ, McMahon DJ, Shane E (2011) Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs. Epilepsy Behav 21:453\u2013458","journal-title":"Epilepsy Behav"},{"key":"109_CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","volume":"10","author":"SH Kim","year":"2007","unstructured":"Kim SH, Lee JW, Choi KG, Chung HW, Lee HW (2007) A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 10:291\u2013295","journal-title":"Epilepsy Behav"},{"key":"109_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","volume":"47","author":"S Mintzer","year":"2006","unstructured":"Mintzer S, Boppana P, Toguri J, DeSantis A (2006) Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 47:510\u2013515","journal-title":"Epilepsia"},{"key":"109_CR15","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","volume":"52","author":"K Heo","year":"2011","unstructured":"Heo K, Rhee Y, Lee HW, Lee SA, Shin DJ, Kim WJ, Song HK, Song K, Lee BI (2011) The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 52:1884\u20131889","journal-title":"Epilepsia"},{"key":"109_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","volume":"47","author":"J French","year":"2001","unstructured":"French J, Edrich P, Cramer JA (2001) A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 47:77\u201390","journal-title":"Epilepsy Res"},{"key":"109_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/11202830-000000000-00000","volume":"71","author":"KA Lyseng-Williamson","year":"2011","unstructured":"Lyseng-Williamson KA (2011) Levetiracetam: a review of its use in epilepsy. Drugs 71:489\u2013514","journal-title":"Drugs"},{"key":"109_CR18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","volume":"104","author":"DL Koo","year":"2013","unstructured":"Koo DL, Joo EY, Kim D, Hong SB (2013) Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 104:134\u2013139","journal-title":"Epilepsy Res"},{"key":"109_CR19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","volume":"21","author":"SA Beniczky","year":"2012","unstructured":"Beniczky SA, Viken J, Jensen LT, Andersen NB (2012) Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure 21:471\u2013472","journal-title":"Seizure"},{"key":"109_CR20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2012.2203","volume":"69","author":"T Hakami","year":"2012","unstructured":"Hakami T, Todaro M, Petrovski S, Macgregor L, Velakoulis D, Tan M, Matkovic Z, Gorelik A, Liew D, Yerra R, O\u2019Brien TJ (2012) Substitution monotherapy with levetiracetam vs. older antiepileptic drugs: a randomized comparative trial. Arch Neurol 69:1563\u20131571","journal-title":"Arch Neurol"},{"key":"109_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"109_CR22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.berh.2005.06.004","volume":"19","author":"K Briot","year":"2005","unstructured":"Briot K, Roux C (2005) What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring? Best Pract Res Clin Rheumatol 19:951\u2013964","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"109_CR23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2003.18.9.1650","volume":"18","author":"RJ MacInnis","year":"2003","unstructured":"MacInnis RJ, Cassar C, Nowson CA, Paton LM, Flicker L, Hopper JL, Larkins RG, Wark JD (2003) Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res 18:1650\u20131656","journal-title":"J Bone Miner Res"},{"key":"109_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0404.2006.00705.x","volume":"114","author":"G Zaccara","year":"2006","unstructured":"Zaccara G, Messori A, Cincotta M, Burchini G (2006) Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol Scand 114:157\u2013168","journal-title":"Acta Neurol Scand"},{"key":"109_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","volume":"10","author":"D Weintraub","year":"2007","unstructured":"Weintraub D, Buchsbaum R, Resor SR Jr, Hirsch LJ (2007) Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav 10:105\u2013110","journal-title":"Epilepsy Behav"},{"key":"109_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.eplepsyres.2007.06.002","volume":"76","author":"BJ Steinhoff","year":"2007","unstructured":"Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I (2007) The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Epilepsy Res 76:6\u201314","journal-title":"Epilepsy Res"},{"key":"109_CR27","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.0013-9580.2003.00403.x","volume":"44","author":"IE Leppik","year":"2003","unstructured":"Leppik IE, Biton V, Sander JW, Wieser HG (2003) Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials. Epilepsia 44:1585\u20131587","journal-title":"Epilepsia"},{"key":"109_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.2009.01257.x","volume":"121","author":"R Kuba","year":"2010","unstructured":"Kuba R, Novotna I, Brazdil M, Kocvarova J, Tyrlikova I, Mastik J, Rektor I (2010) Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up. Acta Neurol Scand 121:83\u201388","journal-title":"Acta Neurol Scand"},{"key":"109_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.seizure.2007.05.019","volume":"17","author":"HP Bootsma","year":"2008","unstructured":"Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP (2008) Long-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparison. Seizure 17:19\u201326","journal-title":"Seizure"},{"key":"109_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5698\/1535-7597-13.2.83","volume":"13","author":"A Pack","year":"2013","unstructured":"Pack A (2013) Levetiracetam treatment does not result in broken bones. Epilepsy Curr 13:83\u201384","journal-title":"Epilepsy Curr"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0109-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0109-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0109-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:41:15Z","timestamp":1558698075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0109-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0109-7","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}